First Tracks Biotherapeutics (TRAX) CMO discloses 16,667 PSUs
Rhea-AI Filing Summary
First Tracks Biotherapeutics, Inc. has updated insider ownership information for Chief Medical Officer Paul F. Lizzul, reflecting his holding of 16,667 performance stock units (PSUs). These PSUs relate to common stock and vest in two equal 50% tranches on March 12, 2027 and March 12, 2028, subject to his continued service.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Lizzul Paul F.
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Performance Stock Unit F1 | -- | -- | -- |
Holdings After Transaction:
Performance Stock Unit — 16,667 shares (Direct)
Footnotes (1)
- F1. The PSUs vest and settle over two years; 50% vests on March 12, 2027 and 50% vests on March 12, 2028, subject to the continuing service of the Reporting Person on each vesting date.
Key Figures
Performance stock units held: 16,667 units
Vesting tranche 1: 50%
Vesting tranche 2: 50%
+1 more
4 metrics
Performance stock units held
16,667 units
PSUs held by the Chief Medical Officer after the reported holdings update
Vesting tranche 1
50%
Portion of PSUs vesting on March 12, 2027, subject to continued service
Vesting tranche 2
50%
Portion of PSUs vesting on March 12, 2028, subject to continued service
Exercise / conversion price
$0.0000
Exercise or conversion price per underlying common share for the PSUs
Key Terms
Performance Stock Unit, underlying security title, vest and settle
3 terms
Performance Stock Unit financial
"security_title: Performance Stock Unit; underlying security is Common Stock"
A performance stock unit is a type of reward companies give to employees, usually managers, that depends on how well the company performs over time. If the company hits specific goals, the employee earns shares of stock, like earning a prize for reaching certain levels in a game. It motivates employees to work hard because their rewards are tied to the company's success.
underlying security title financial
"underlying_security_title: Common Stock for the performance stock units"
vest and settle financial
"The PSUs vest and settle over two years; 50% vests on March 12, 2027"
FAQ
What does First Tracks Biotherapeutics (TRAX) disclose in this Form 3/A amendment?
The amendment shows that Chief Medical Officer Paul F. Lizzul holds 16,667 performance stock units (PSUs). These units are tied to common stock and vest over two years, updating the previously reported insider ownership details.
How many performance stock units does the TRAX Chief Medical Officer hold?
Chief Medical Officer Paul F. Lizzul is reported to hold 16,667 performance stock units. Each PSU is linked to First Tracks Biotherapeutics common stock, giving him rights to receive shares as the units vest over the specified schedule.
What is the vesting schedule for the 16,667 PSUs reported by TRAX?
The 16,667 PSUs vest and settle over two years: 50% on March 12, 2027 and 50% on March 12, 2028. Vesting is conditioned on Paul F. Lizzul’s continued service with First Tracks Biotherapeutics on each vesting date.
How are the reported TRAX performance stock units linked to common stock?
The reported PSUs are tied to First Tracks Biotherapeutics common stock as the underlying security. Upon vesting and settlement, each unit represents the right to receive shares of common stock at a stated exercise price of $0.0000 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
